# High loss to follow-up on a bedaquiline-based regimen for rifampicin-resistant TB

**Authors:** F. Idowu, T. Decroo, A. Mesic

PMC · DOI: 10.5588/ijtldopen.25.0261 · 2025-11-12

## Full-text entities

- **Diseases:** TB (MESH:D014390)
- **Chemicals:** bedaquiline (MESH:C493870), rifampicin (MESH:D012293)

---
Source: https://tomesphere.com/paper/PMC12617080